Stifel Maintains Buy on Edwards Lifesciences, Raises Price Target to $105

Benzinga · 4d ago
Stifel analyst Rick Wise maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $100 to $105.